Showing results (1-10 of 195) with videos related to
Sort By:
Pageof 20
Seminars in Nuclear Medicine|December 19, 2016
Recent Developments in Molecular Brain Imaging of Neuropsychiatric DisordersMark Slifstein, Anissa Abi-DarghamHandbook of Clinical Neurology|October 14, 2014
Molecular imaging in alcohol dependenceShervin Ravan, Diana Martinez, Mark Slifstein, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 18, 2019
A positron emission tomography occupancy study of brexpiprazole at dopamine D2 and D3 and serotonin 5-HT1A and 5-HT2A receptors, and serotonin reuptake transporters in subjects with schizophreniaRagy R Girgis, Andy Forbes, Anissa Abi-Dargham, et al.Biological Psychiatry|January 27, 2009
Baseline and amphetamine-stimulated dopamine activity are related in drug-naïve schizophrenic subjectsAnissa Abi-Dargham, Elsmarieke van de Giessen, Mark Slifstein, et al.Neuroscience and Biobehavioral Reviews|December 12, 2018
From "bedside" to "bench" and back: A translational approach to studying dopamine dysfunction in schizophreniaAnissa Abi-DarghamThe International Journal of Neuropsychopharmacology|February 20, 2004
Do we still believe in the dopamine hypothesis? New data bring new evidenceAnissa Abi-DarghamThe Journal of Clinical Psychiatry|December 4, 2014
Schizophrenia: overview and dopamine dysfunctionAnissa Abi-DarghamWorld Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 2, 2006
Probing cortical dopamine function in schizophrenia: what can D1 receptors tell us?Anissa Abi-DarghamJournal of Psychiatry and Brain Science|September 17, 2021
Relevance of the Kappa Dynorphin System to Schizophrenia and Its TherapeuticsAnissa Abi-DarghamInternational Review of Neurobiology|March 14, 2007
Alterations of serotonin transmission in schizophreniaAnissa Abi-DarghamPageof 20